UK Agency Investigating Anaphylactoid Reactions From COVID-19 Vaccine

The British Medical Journal (BMJ) reported the UK's Medicines and Healthcare Products Regulatory Agency (MHRA) is currently investigating (2) cases of anaphylactoid reactions in NHS staff who received the experimental vaccine BNT162b2 on December 8, 2020. Both people had a history of severe allergic reactions and carried adrenaline auto-injectors.

The MHRA has informed people running BNT162b2 vaccination sites in the UK to report any suspected adverse reactions and to ensure that they have appropriate resuscitation facilities available, stated the BMJ's Elisabeth Mahase, on December 10, 2020.